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INTRODUCTION
Slow wave sleep (SWS) is regulated accurately in response to sustained wakefulness and has been theorised as reflecting a homeostatic sleep process. 1 SWS is thought to contribute substantially to the recuperation from the effects of sustained wakefulness. [2] [3] [4] As a result stimulation of SWS via medications and devices has been attempted in the hope of producing more restorative sleep. [5] [6] [7] SWS is identified on the basis of the presence of slow waves with an amplitude greater than 75 microvolts in the electroencephalogram (EEG). SWS declines markedly with age; whereas in adults aged between 40-54 approximately 18.2% of sleep time consist of SWS, this drops to around 15.8% in adults aged 61-70. 8 In patients with severe obstructive sleep apnea (OSA), SWS is significantly reduced secondary to increased sleep fragmentation. 8 For instance in 93 of our severe OSA patients (average 46 years), mean SWS was 11%. 9 In contrast, in our department, increased SWS% has frequently been observed clinically in patients with hypercapnic respiratory failure. This phenomenon is not easily explained by current understanding of factors affecting sleep architecture in sleep-breathing disorders. 10 A few studies of patients with nocturnal respiratory failure have quantified SWS but none have reported this phenomenon. [11] [12] [13] [14] Interestingly, previous animal studies have shown that hypercapnia, acute or chronic, can lead to slowing of EEG in eels 15 , rats 16 , rabbits 17 , and dogs 18 . Extreme hypercapnia can produce an isoelectric EEG in cats 19 and this has also been observed in a single case report in humans. 20 We hypothesise that respiratory failure patients will have greater SWS% than normative age-matched controls from previously published studies 8 and that SWS% in respiratory failure patients will be positively correlated with hypercapnia.
METHODS
The study was conducted at the clinical sleep laboratory of Royal Prince Alfred Hospital, a teaching hospital of the University of Sydney. We retrieved sleep and arterial blood gas (ABG) data from all the respiratory failure patients who underwent polysomnography (PSG) with administered bilevel non-invasive ventilation (NIV) therapy in our centre from January 2008 to July 2009. Most of these respiratory failure patients were being screened for other research protocols conducted at our department (SSWAHS ethics approval number:
3 OHS X03-0022), and all patients signed written informed consent before the sleep studies, allowing deidentified data to be used for research audit purposes. Stepwise multiple linear regression analyses were used to identify factors associated with SWS. ANOVA was used to test between subject effects among the subtypes of respiratory failure patients. In the subset with
PSGs done with and without NIV, predictors of SWS% were compared between the two nights using a random intercept linear mixed model. Analyses were performed using SPSS 17. A p < 0.05 was considered as significant.
RESULTS

NIV study
The 97 patients could be categorized into 6 subtypes according to the cause of the disease: a) 24 The overall SWS% was positively correlated with awake daytime PCO 2 (r=0.35, p=0.001, see Figure 1 ) and with % Total sleep time with SpO 2 below 90% (%T90) (rho=0.22, p=0.035). We stratified the 97 patients into the six subtypes and found that the correlations between SWS% and PCO 2 were only significant in Overlap syndrome and OHS subtypes ( increase. However, the best predictor for the increased SWS time, PCO 2 , did not correlate to either sleep latency or sleep efficiency (p>0.5). Similar to the NIV study, we found a significant positive correlation between awake PCO 2 and SWS% in the 32 initial diagnostic studies (r=0.40, p=0.025, see Figure 2 ). Female subjects (n=19) had higher SWS% than the 13 male patients (27.3±24.1% vs. 17.9±15.6%, p=0.16).
Patients with both Diagnostic and NIV data (n= 32)
To explore the reasons for SWS% increasing from the diagnostic to the NIV night, concurrently with a fall in PCO 2 , mixed effects models were fitted to data from n=32 patients with PSG data from both nights analysed.
The full model included predictors gender, arousal index, PCO 2 , night (diagnostic vs. NIV) and the night*PCO 2 interaction, while the dependent variable was SWS%. There was no significant night*PCO 2 interaction, indicating no difference in the positive relationship between PCO 2 and SWS% between the two nights (p=0.7). Mixed linear regression indicated that PCO 2 (p=0.009), gender (p=0.009) and arousal index (p=0.03) remain significant independent predictors of SWS% across both nights, but night was not a significant predictor. The latter also suggests that the rise in SWS% despite a fall in PCO 2 between diagnostic and NIV nights (Table 3) can be explained by the concomitant improvement in sleep quality as expressed by the fall in arousal index.
DISCUSSION
As we hypothesised respiratory failure patients have much higher proportion of slow wave sleep than a reference normal population. 8 In addition the SWS% was positively associated with daytime hypercapnia.
The association was found in both initial diagnostic PSG and in subsequent NIV treatment studies, indicating that the high SWS is not due to a rebound effect from NIV use. The relationship was particularly apparent in OHS and overlap syndrome subtypes which can not be easily explained by our data. The increased SWS may also be a marker of increased overall sleep drive with decreased sleep latency and increased sleep efficiency.
Our multiple regression results suggest three mechanisms involved with the increased SWS%.
Hypercapnia
Our 97 patients predominantly had hypercapnic respiratory failure and PCO 2 was the best predictor for the increased SWS time. To our knowledge, this phenomenon has not previously been reported in observational studies, although few clinical studies have reported SWS data in respiratory failure samples. [11] [12] [13] [14] In a study conducted in 1976, the authors reported "greater than expected stage 4 sleep" (>11%) in 4 out of 10 chronic ventilatory failure patients which is "surprising for their age group"(48-66 yrs). 11 The 10 patients had an average awake PCO 2 of 57mmHg which is similar to our patient group (mean PCO 2 58±10.9 mmHg). The authors did not discuss this observation further, possibly due to small sample size. In 1982, a study compared sleep architecture in 24 severe COPD patients before and after O 2 therapy with that of age-matched healthy control participants. 14 . Although the exact numerical effect was not reported, a figure showed that compared to the normal participants, the SWS% in "COPD on air" was more than doubled, and the SWS% in "COPD on O 2 " was more than tripled. This finding was not discussed. 14 But our data did not yield a significant association between PCO 2 and SWS in the pure lung disease subgroup. The superior sample size in our study allowed us to investigate the potential effects of patient heterogeneity on the association between hypercapnia and SWS. In addition, the severity of hypercapnia in conjunction with a wide spread in hypercapnia in our patients allowed us greater statistical power to detect effects on SWS than was available to the previous investigators.
Because previous experimental studies in both animals and humans have shown that hypercapnia causes increases in SWS we believe that the biologically plausibility of the clinical association we report here is already established. In a human study PaCO 2 levels were manipulated in 18 anesthetized elective surgery patients to achieve hypocapnia (PaCO 2 =20mmHg), normocapnia (PaCO 2 =38mmHg) and hypercapnia (PaCO 2 =50mmHg). 24 Acute hypercapnia (PaCO 2 =50mmHg) was found to cause a significant decrease of power in the alpha and beta EEG bands, whereas delta and theta power remained unchanged. 24 In contrast, previous animal studies have suggested that both acute 15, 16, 18 and chronic hypercapnia 17 are associated with increased delta waves in EEG. After giving 30 seconds of 80% CO 2 , EEG traces in rats (under light anesthesia with N 2 O) were dominated by slow waves. 16 Relative percentage EEG power (Frequency analysis)
dropped from 100% to 56.4% by 45 seconds. Thirty seconds after cessation of 80% CO 2 , this metric began to recover and 4 minute later recovered to 75% 16 Similar findings have also been reported in dogs 18 and eels 15 .
In a chronic hypercapnia model of 13 rabbits (without anesthesia) exposed to an air mixture containing an increasing amount of CO 2 over an eight-week period, arterial CO 2 increased to 60mmHg and mean EEG frequency dropped by 10Hz. 17 The rabbits became extremely apathic and brain edema was confirmed by electron microscope. The authors proposed that the slowing of EEG and the accompanying behavioural change may signal a depression in vital activities caused by chronic hypercapnia. 17 We speculate that the mechanism may also apply to our clinical patients, the large amounts of SWS we found may not represent changes in SWS similar to those caused by sustained wakefulness. The exact biological reason for the increased SWS in our patients is unclear. However, SWS in our patients is associated with the same factors that are associated with SWS in normal people, namely sleep interruption/arousal and gender.
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Our findings may also be related to the description of "Paradoxical Delta Activity" during anaesthesia. 25 Although this phenomenon was attributed to noxious stimulation causing cortical arousal 25 , substantial variation in PCO 2 may occur in anesthetized patients, especially in those with hypercapnic respiratory failure.
Arousal
Frequent sleep interruption/ sleep fragmentation is an important factor affecting SWS. In our SWS analysis the second most powerful association was the negative association with arousal index. In addition, the comparison of sleep before and after NIV intervention showed a significant negative relationship between the change of arousal index and the change of SWS%. This is not surprising as SWS in severe OSA patients is significantly disturbed by frequent arousals. 8 After implementing NIV, sleep fragmentation was reduced and SWS significantly increased despite a reduction of PCO 2 . This may suggest that the dramatic reduction of arousals from the introduction of NIV played a more dominant role than the more minor shift in PCO 2 in determining SWS changes within patients. However, the correlation between patients on any single night of observation is that PCO 2 correlates more strongly with SWS than ArI does.
Gender
We also found that female gender is a significant predictor for the increased SWS time in our patients independent of age, AHI, ArI, overnight SpO 2 , awake PCO 2 and disease subtype. This is not a new observation as females have long been noted to have greater amounts of SWS and concomitantly greater EEG power in the delta frequency 8 , 26 ,27 _ENREF_28 Our study confirms that this gender effect is still evidence even in the context of severe hypercapnia.
Study limitations
We tried to minimize the retrospective limitation of our study by retrieving initial diagnostic PSG studies and comparing with their latter NIV treatment studies. However, a large proportion of patients commenced NIV on an emergency basis and did not undergo full diagnostic polysomnography. Also, some initial diagnostic PSG studies were not conducted at our laboratory. To maintain high quality standardisation of data, we excluded those studies. Therefore, only 32 out of 97 studies were included in final diagnostic study analyses.
We are aware of the pitfalls related to this and therefore verified our findings with the diagnostic studies 10 using mixed model analysis. In our NIV studies, the PtcCO 2 measurements were not calibrated as they were used to indicate trends, and therefore they were not included in our analysis. Instead, we used awake ABG PCO 2 to represent the degree of hypercapnia. We can only speculate that, generally speaking, patients with daytime hypercapnia will be further worse off with sleep depressing respiration and that daytime and night-time hypercapnia are substantively correlated. A potential confounding factor is that some patients were O 2 dependant and the investigations were performed with O 2 supplementation or immediately off oxygen, which could affect PCO 2 and SpO 2 results. Most of our patients were taking different medications and it is nearly impossible to find a medication free respiratory failure group.
Nevertheless, none of the related medications has proven effects of increasing SWS which could significantly bias our study results. Our approach of not excluding patients on arbitrary criteria does however have an advantage because we are reasonably confident that these patients represent a general cross-section of our normal respiratory failure population. It is also possible that application of quantitative EEG analysis methods 28 to these data may provide superior resolution compared to standard visual scoring. Another limitation is that the sample size in some of the subtypes was small (due to rarity of the diseases), which limited statistical power. Caution should be exercised in concluding the absence of associations in any given subtype.
In summary, patients with respiratory failure have a paradoxically high amount of SWS. In these patients, SWS is positively correlated to PCO 2 , particularly in OHS and overlap syndrome subtypes. 
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